HAVCR2 and cancer: Sauer Sauer N N Janicka Janicka N N Szlasa Szlasa W W TIM-3 as a promising target for cancer immunotherapy in a wide range of tumors TIM-3 as a promising target for cancer immunotherapy in a wide range of tumors Cancer Immunol Immunother Cancer Immunol Immunother 2023 2023 72 72 3405 3405 3425 3425 10.1007/s00262-023-03516-1 10.1007/s00262-023-03516-1 supplied-pmid 37567938?